MedTrace Logo

Evaluation of the 24/7 EEG™ SubQ System in Subjects With Uncontrolled Genetic Generalised Epilepsy Syndrome

NCT05241678 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 13

Last updated 2024-03-07

No results posted yet for this study

Summary

This study is a 12 week prospective, comparative investigation in subjects diagnosed with uncontrolled genetic generalised epilepsy (GGE) also known as idiopathic generalised epilepsy (IGE). The purpose of the study is to evaluate whether the 24/7 EEG™ SubQ system, a subcutaneous implantable device, will demonstrate seizure sensitivity approximating that of inpatient video-EEG monitoring with the standard 10-20 electrode system.

Conditions

  • Epilepsy, Generalized

Sponsors & Collaborators

  • UNEEG Medical A/S

    collaborator INDUSTRY

  • Science Foundation Ireland

    collaborator OTHER

  • Royal College of Surgeons, Ireland

    lead OTHER

Principal Investigators

  • Norman Delanty, MD · Royal College of Surgeons, Dublin, Ireland

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-02-15
Primary Completion
2023-12-29
Completion
2023-12-29

Countries

  • Ireland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05241678 on ClinicalTrials.gov